Parkinson Agent Tavapadon Shows Continued Efficacy, Safety in Phase 3 TEMPO-4 Trial | NeurologyLive – Clinical Neurology News and Neurology Expert Insights
October 18, 2025
All about the disease
Emerging research is exploring the potential of photobiomodulation (PBM) – a light-based therapy targeting the gut-brain axis- as a promising new treatment for Parkinson’s disease.